
Check-Cap Ltd. CHEK
Check-Cap Ltd. Betriebsaufwand | CHEK
Betriebsaufwand Jährlich Check-Cap Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 14.1 M | 11.1 M | 10 M | 9.06 M | 12.5 M | 4.81 M | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.1 M | 4.81 M | 10.2 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Biomerica
BMRA
|
5.68 M | $ 1.69 | 0.6 % | $ 4.93 M | ||
|
Myriad Genetics
MYGN
|
964 M | $ 6.03 | 3.52 % | $ 558 M | ||
|
Pacific Biosciences of California
PACB
|
600 M | $ 2.25 | 6.64 % | $ 675 M | ||
|
Neuronetics
STIM
|
104 M | $ 2.26 | 7.11 % | $ 149 M | ||
|
Agilent Technologies
A
|
1.99 B | $ 175.77 | 1.56 % | $ 49.9 B | ||
|
Charles River Laboratories International
CRL
|
607 M | $ 357.54 | 3.52 % | $ 17.7 B | ||
|
Fulgent Genetics
FLGT
|
222 M | $ 20.23 | 0.65 % | $ 623 M | ||
|
Guardant Health
GH
|
226 M | $ 173.31 | 2.5 % | $ 21.7 B | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 328.03 | -0.28 % | $ 27.3 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 99.94 | 0.14 % | $ 6.74 B | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 666.34 | -0.24 % | $ 34.3 B | ||
|
ENDRA Life Sciences
NDRA
|
5.76 M | $ 4.82 | 0.42 % | $ 3.79 M | ||
|
NeoGenomics
NEO
|
430 M | $ 16.7 | 0.63 % | $ 2.14 B | ||
|
Neogen Corporation
NEOG
|
430 M | $ 12.22 | 0.21 % | $ 2.66 B | ||
|
National Research Corporation
NRC
|
38.5 M | $ 22.54 | 2.78 % | $ 505 M | ||
|
Natera
NTRA
|
258 M | $ 404.77 | 0.2 % | $ 55.3 B | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 11.74 | -0.68 % | $ 123 M | ||
|
OPKO Health
OPK
|
187 M | $ 1.63 | 1.23 % | $ 1.22 B | ||
|
Trinity Biotech plc
TRIB
|
28.3 M | $ 7.3 | -0.06 % | $ 2.62 B | ||
|
T2 Biosystems
TTOO
|
38.2 M | - | -39.35 % | $ 313 K | ||
|
Bioventus
BVS
|
217 M | $ 14.75 | -1.44 % | $ 983 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
Precipio
PRPO
|
11.9 M | $ 19.5 | -2.55 % | $ 31.3 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
QIAGEN N.V.
QGEN
|
834 M | $ 50.36 | -0.07 % | $ 10.9 B | ||
|
RadNet
RDNT
|
1.98 B | $ 69.9 | -0.63 % | $ 5.26 B | ||
|
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 26.55 | -1.28 % | $ 25.2 B | ||
|
Senseonics Holdings
SENS
|
61.8 M | $ 7.46 | -0.67 % | $ 311 M | ||
|
Sotera Health Company
SHC
|
305 M | $ 18.35 | 1.35 % | $ 5.21 B | ||
|
Thermo Fisher Scientific
TMO
|
7.15 B | $ 684.39 | 1.57 % | $ 258 B | ||
|
Twist Bioscience Corporation
TWST
|
116 M | $ 145.39 | 3.91 % | $ 8.7 B | ||
|
Celcuity
CELC
|
172 M | $ 65.75 | 0.76 % | $ 3.07 B | ||
|
VolitionRx Limited
VNRX
|
23.5 M | $ 0.18 | 0.83 % | $ 22.6 M | ||
|
Waters Corporation
WAT
|
687 M | $ 456.36 | 0.39 % | $ 27.2 B | ||
|
Exagen
XGN
|
40.6 M | $ 7.44 | 2.34 % | $ 160 M | ||
|
Quotient Limited
QTNT
|
119 M | - | -11.32 % | $ 1.1 M | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
Surmodics
SRDX
|
26.4 M | - | - | $ 608 M | ||
|
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | ||
|
Syneos Health
SYNH
|
4.12 B | - | - | $ 4.46 B | ||
|
Motus GI Holdings
MOTS
|
19.1 M | - | -34.28 % | $ 263 K | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 32.84 | -0.73 % | $ 952 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Renalytix AI plc
RNLX
|
29.8 M | - | 5.66 % | $ 22.7 M | ||
|
Psychemedics Corporation
PMD
|
8.99 M | - | -1.84 % | $ 15.3 M | ||
|
Meridian Bioscience
VIVO
|
134 M | - | - | $ 1.49 B |